| abstract |
The present invention relates to novel compounds of Formula I or pharmaceutically acceptable salts thereof, which have inverse agonist or histamine H3 receptor antagonist activity, as well as methods for preparing such compounds. In another embodiment, the invention describes pharmaceutical compositions comprising compounds of Formula I, as well as methods for using them to treat obesity, cognitive deficits, narcolepsy and other diseases related to the histamine H3 receptor. (See formula (I)). |